div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: The Food and Drug Administration FDA issued Circular No 2020-006 entitled Guidance for Applications and Transactions at the Food and Drug Administration in Light of the Community src=https:reader033fdocumentsusreader033viewer2022052010602048d56d100a5873244994html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: The Food and Drug Administration FDA issued Circular No 2020-006 entitled Guidance for Applications and Transactions at the Food and Drug Administration in Light of the Community src=https:reader033fdocumentsusreader033viewer2022052010602048d56d100a5873244994html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: The Food and Drug Administration FDA issued Circular No 2020-006 entitled Guidance for Applications and Transactions at the Food and Drug Administration in Light of the Community src=https:reader033fdocumentsusreader033viewer2022052010602048d56d100a5873244994html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: The Food and Drug Administration FDA issued Circular No 2020-006 entitled Guidance for Applications and Transactions at the Food and Drug Administration in Light of the Community src=https:reader033fdocumentsusreader033viewer2022052010602048d56d100a5873244994html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdiv